| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 181,878 | 183,365 | 184,260 | 354,825 | | Cost of Revenue | 135,935 | 135,362 | 136,342 | 270,129 | | | Gross Profit | 45,943 | 48,003 | 47,918 | 84,696 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 65,041 | 64,493 | 64,513 | 97,133 | | Non Recurring | 464 | 329 | 5,747 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (19,562) | (16,819) | (22,342) | (12,437) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (19,562) | (16,819) | (22,342) | (12,437) | | Interest Expense |
-
| 2,851 | 2,836 | 2,983 | | Income Before Tax | (22,241) | (19,670) | (25,178) | (15,420) | | Income Tax Expense | 37 | 148 | 212 | 2,024 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (22,278) | (19,818) | (25,390) | (17,444) | | | Non-recurring Events | | Discontinued Operations | 221 | (945) | (16,189) | (823) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (22,057) | (20,763) | (41,579) | (18,267) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($22,057) | ($20,763) | ($41,579) | ($18,267) |
|
0.11% Nasdaq 
0.01%
Income Statement
